INTEGRATED BIOPHARMA INC Quarterly Share-based Payment Arrangement, Expense in USD from Q4 2020 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Integrated Biopharma Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q4 2020 to Q1 2022.
  • Integrated Biopharma Inc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2022 was $49K, a 47.9% decline year-over-year.
  • Integrated Biopharma Inc annual Share-based Payment Arrangement, Expense for 2021 was $231K, a 292% increase from 2020.
  • Integrated Biopharma Inc annual Share-based Payment Arrangement, Expense for 2020 was $59K, a 59% decline from 2019.
  • Integrated Biopharma Inc annual Share-based Payment Arrangement, Expense for 2019 was $144K, a 929% increase from 2018.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $49K -$45K -47.9% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $145K +$60K +70.6% Oct 1, 2021 Dec 31, 2021 10-Q 2022-02-10
Q1 2021 $94K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $85K Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.